ENLIGHTEN HEALTH - Trademark Details
Status: 730 - First Extension - Granted
Serial Number
88581014
Word Mark
ENLIGHTEN HEALTH
Status
730 - First Extension - Granted
Status Date
2021-12-01
Filing Date
2019-08-15
Mark Drawing
4000 - Standard character mark
Typeset
Published for Opposition Date
2021-04-06
Attorney Name
Law Office Assigned Location Code
L90
Employee Name
ANKRAH, NAAKWAMA S
Statements
Disclaimer with Predetermined Text
"HEALTH"
Goods and Services
Business consultancy, business management consultancy, business strategy advisory and marketing services for pharmaceutical, medical device, food and healthcare companies; business consulting services, business strategy advisory services and marketing services relating to the development, formulation and testing of pharmaceuticals, bio-technology products and medical devices; business consulting services, business strategy advisory services and marketing services relating to conducting of clinical trials; business consulting services, business strategy advisory services and marketing services relating to the commercialization of pharmaceutical products, bio-technological products or medical devices; business consulting services, business strategy advisory services and marketing services relating to lead candidate drug optimization; business organization consultancy; retail store and wholesale store services featuring pharmaceutical, veterinary and sanitary preparations and medical supplies; personnel recruitment; business project management services in the fields of clinical and non-clinical programs, clinical and non-clinical drug development and research studies, clinical and non-clinical trials or proof of concept trials; business consultation in the nature of design and development of market access strategies; implementation of market access strategies and processes on behalf of others for business purposes; business data analysis and reporting, review and analysis of medical and clinical data for third parties and providing a report on the meaning of such data to third parties for business cost analysis; business consultation services in the market authorization of drugs; commercial administration of the licensing of the goods and services of others; compilation of information into computer databases; business advisory services, business consultancy services, business data analysis, business information services, business management consulting, business strategy services, market research, marketing services, database management, and business project management services, all in the fields of medical testing, testing for forensic purposes, testing for quality control purposes, genetic testing, clinical and analytical testing, disease, medical care, healthcare, pharmaceuticals, medical devices, biochemicals, and biotechnology; regulatory submission management, namely, assisting others in preparing and filing applications with governmental regulatory bodies for approval of new drugs and medical devices; business management services, namely, supply and demand forecasting drug supplies for clinical trials; business management services, namely, recruiting patients and volunteers for clinical trials; business administration of patient reimbursement programs; Business services provided to the health care industry, namely, consulting services, market intelligence, data collection, data submission and patient management; holding company services, namely, providing ownership cost analyses, financial control audits, and business information reporting services for subsidiaries and affiliates; holding company services, namely, providing business management and business administration services for subsidiaries and affiliates
Goods and Services
Providing a database featuring information and statistics about patient reimbursement and insurance coverage for pharmaceuticals and medical devices; financial administration of patient reimbursement programs
Goods and Services
Advisory services relating to regulatory compliance in the fields of pharmaceuticals and medical devices; monitoring of regulatory compliance in non-clinical and clinical pharmaceutical and medical device trials; investigation of assets, preparation and review of reports and assessments for regulatory purposes; providing information and advice regarding regulatory compliance; regulatory compliance consulting in the fields of pharmaceuticals and medical devices; regulatory compliance consulting in the field of obtaining government authorization to market pharmaceuticals and medical devices
Classification Information
International Class
035 - Advertising; business management; business administration; office functions. - Advertising; business management; business administration; office functions.
US Class Codes
100, 101, 102
Class Status Code
6 - Active
Class Status Date
2019-08-31
Primary Code
035
International Class
036 - Insurance; financial affairs; monetary affairs; real estate affairs. - Insurance; financial affairs; monetary affairs; real estate affairs.
US Class Codes
100, 101, 102
Class Status Code
6 - Active
Class Status Date
2019-08-31
Primary Code
036
International Class
045 - Personal and social services rendered by others to meet the needs of individuals; security services for the protection of property and individuals. - Personal and social services rendered by others to meet the needs of individuals; security services for the protection of property and individuals.
US Class Codes
100, 101
Class Status Code
6 - Active
Class Status Date
2019-08-31
Primary Code
045
Current Trademark Owners
Party Type
20 - Owner at Publication
Legal Entity Type
03 - Corporation
Address
Please log in with your Justia account to see this address.
Trademark Owner History
Correspondences
Name
William M. Bryner
Address
Please log in with your Justia account to see this address.
Foreign Application Information
Filing Date | Application Number | Country | Foreign Priority Claim In |
2019-02-15 | 076925 | Jamaica | True |
Trademark Events
Event Date | Event Description |
2019-08-19 | NEW APPLICATION ENTERED IN TRAM |
2019-08-31 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM |
2019-09-28 | ASSIGNED TO EXAMINER |
2019-10-05 | NON-FINAL ACTION WRITTEN |
2019-10-05 | NON-FINAL ACTION E-MAILED |
2019-10-05 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
2020-03-30 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
2020-03-30 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
2020-03-30 | TEAS/EMAIL CORRESPONDENCE ENTERED |
2020-05-14 | NON-FINAL ACTION WRITTEN |
2020-05-14 | NON-FINAL ACTION E-MAILED |
2020-05-14 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
2020-11-13 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
2021-02-17 | ASSIGNED TO LIE |
2021-02-17 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
2021-02-17 | TEAS/EMAIL CORRESPONDENCE ENTERED |
2021-03-01 | APPROVED FOR PUB - PRINCIPAL REGISTER |
2021-03-17 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
2021-04-06 | PUBLISHED FOR OPPOSITION |
2021-04-06 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
2021-06-01 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
2021-12-01 | TEAS EXTENSION RECEIVED |
2021-12-01 | EXTENSION 1 FILED |
2021-12-01 | EXTENSION 1 GRANTED |
2021-12-03 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |